Not logged in Share Save
Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials Horan, William P.; Kalali, Amir; Brannan, Stephen K.; Drevets, Wayne; Leoni, Matthew; Mahableshwarkar, Atul; Martin, William J.; Rao, Srinivas; Reuteman-Fowler, Corey; Sauder, Colin; Savitz, Adam; Singh, Jaskaran; Tiller, Jane; Walker, Gary; Wendland, Jens R.; Harvey, Philip D. Share Save
Response to Commentaries Horan, William P.; Kalali, Amir; Brannan, Stephen K.; Drevets, Wayne; Mahableshwarkar, Atul; Rao, Srinivas; Reuteman-Fowler, Corey; Savitz, Adam; Singh, Jaskaran; Walker, Gary; Wendland, Jens R.; Harvey, Philip D. Share Save
Share Save
Share Save
Share Save
INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia Murthy, Venkatesha; Hanson, Elizabeth; Demartinis, Nicholas; Asgharnejad, Mahnaz; Dong, Cheng; Evans, Rebecca; Ge, Tingting; Dunayevich, Eduardo; Singh, Jaskaran B.; Ratti, Emiliangelo; Galderisi, Silvana Share Save
Share Save
Share Save
Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal spray Turkoz, Ibrahim; Nelson, Craig; Wilkinson, Samuel T.; Borentain, Stephane; Macaluso, Matthew; Trivedi, Madhukar H.; Williamson, David; Sheehan, John J.; Salvadore, Giacomo; Singh, Jaskaran; Daly, Ella Share Save
Share Save
Share Save
Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies Doty, Richard L.; Popova, Vanina; Wylie, Crystal; Fedgchin, Maggie; Daly, Ella; Janik, Adam; Ochs-Ross, Rachel; Lane, Rosanne; Lim, Pilar; Cooper, Kim; Melkote, Rama; Jamieson, Carol; Singh, Jaskaran; Drevets, Wayne C. Share Save
Share Save
Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant Hudgens, Stacie; Floden, Lysbeth; Blackowicz, Michael; Jamieson, Carol; Popova, Vanina; Fedgchin, Maggie; Drevets, Wayne C.; Cooper, Kimberly; Lane, Rosanne; Singh, Jaskaran Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
